Pure Global
NCT06118554

3D Printing to Improve Nasal Irrigation Outcome

3D Printing for Topical Nasal Corticosteroid Irrigations: a Randomized Clinical Trial.
Ohio State University·ClinicalTrials.gov·otherRecruitment Completed
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Chronic Rhinosinusitis With Nasal Polyps,Chronic Rhinosinusitis Without Nasal Polyps
Drug/Device/Intervention
Irrigation head position
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Ohio State University
Location
Columbus, United States of America
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2021
End date
Dec 30, 2024
Enrollment
62 participants
Primary outcome

Nasal Obstruction Symptom Evaluation (NOSE) score,22-item Sino-Nasal Outcome Test (SNOT-22) score,Visual Analogue Scale (VAS) of nasal congestion score,Lund-Mackay (LM) score of sinus inflammation.

Summary

Three-dimensional (3D) printing has been an emerging technology with uses in a wide array of
 fields. This research aims to use 3D printing as a tool to provide personalized education to
 maximize treatment efficacy based on the patient's individual anatomy. With increased
 irrigation to the sinuses, we hypothesize there will be improved patient satisfaction and
 higher quality of life. The outcomes of this research could lead to a new option for patients
 who live with chronic rhinosinusitis are not candidates for surgery or are interested in less
 invasive options. The 3D printed nasal replica is not something that would be implanted,
 rather it is a hand-held device used specifically for participants to better understand their
 nasal anatomy.

ICD-10 classifications
Nasal polypNasal polyp, unspecifiedPolyp of nasal cavityOther polyp of sinusOther chronic sinusitis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06118554
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06118554 through Pure Global AI's free database. This phase not specified trial is sponsored by Ohio State University and is currently Recruitment Completed. The study focuses on Chronic Rhinosinusitis With Nasal Polyps,Chronic Rhinosinusitis Without Nasal Polyps. Target enrollment is 62 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.